Compare, Analyse ALEMBIC PHARMA with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC PHARMA   ACTAVIS
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
ACTAVIS
Dec-18
ALEMBIC PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs66414,276-   
Low Rs4129,577-   
Sales per share (Unadj.) Rs208.73,502.0-  
Earnings per share (Unadj.) Rs31.0-1,128.0-  
Cash flow per share (Unadj.) Rs37.1369.0-  
Dividends per share (Unadj.) Rs5.500-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs144.214,444.1-  
Shares outstanding (eoy) m188.52332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.63.4 75.7%   
Avg P/E ratio x17.4-10.6 -164.2%  
P/CF ratio (eoy) x14.532.3 44.9%  
Price / Book Value ratio x3.70.8 452.0%  
Dividend payout %17.70-   
Avg Mkt Cap Rs m101,4613,966,766 2.6%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m7,4670-   
Avg. sales/employee Rs ThNM68,921.0-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-22,199.5-  
INCOME DATA
Net Sales Rs m39,3471,164,765 3.4%  
Other income Rs m9422,274 0.4%   
Total revenues Rs m39,4411,187,039 3.3%   
Gross profit Rs m8,73630,523 28.6%  
Depreciation Rs m1,152497,912 0.2%   
Interest Rs m18467,214 0.3%   
Profit before tax Rs m7,493-512,328 -1.5%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m0130,664 0.0%   
Tax Rs m1,568-6,493 -24.1%   
Profit after tax Rs m5,844-375,171 -1.6%  
Gross profit margin %22.22.6 847.2%  
Effective tax rate %20.91.3 1,650.7%   
Net profit margin %14.9-32.2 -46.1%  
BALANCE SHEET DATA
Current assets Rs m19,577477,726 4.1%   
Current liabilities Rs m14,896422,612 3.5%   
Net working cap to sales %11.94.7 251.4%  
Current ratio x1.31.1 116.3%  
Inventory Days Days9020 458.2%  
Debtors Days Days4566 68.4%  
Net fixed assets Rs m27,097131,845 20.6%   
Share capital Rs m3770-   
"Free" reserves Rs m26,8110-   
Net worth Rs m27,1884,804,111 0.6%   
Long term debt Rs m4,9931,691,702 0.3%   
Total assets Rs m47,7787,509,919 0.6%  
Interest coverage x41.7-6.6 -629.7%   
Debt to equity ratio x0.20.4 52.2%  
Sales to assets ratio x0.80.2 531.0%   
Return on assets %12.6-4.1 -307.7%  
Return on equity %21.5-7.8 -275.2%  
Return on capital %23.6-4.8 -487.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m13,3880-   
CASH FLOW
From Operations Rs m8,120416,127 2.0%  
From Investments Rs m-7,556228,607 -3.3%  
From Financial Activity Rs m590-714,198 -0.1%  
Net Cashflow Rs m1,153-69,117 -1.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.78 Rs / USD

Compare ALEMBIC PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ALEMBIC PHARMA With: CIPLA  AJANTA PHARMA  SUN PHARMA  AUROBINDO PHARMA  FULFORD INDIA  



Today's Market

Sensex Ends 272 Points Higher; Hindalco, Hero MotoCorp & Wipro Surge Over 4%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views On News

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

Power Grid's InvIT IPO: Key Points to Consider (Company Info)

Apr 23, 2021

In this article, we discuss the key reasons why the stock of Power Grid was in focus today.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Learn: How to Potentially Accumulate Rs 7 Crore in Wealth Over the Long-term
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ALEMBIC PHARMA SHARE PRICE


May 6, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS